NewEdge Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.15M | Sell |
73,646
-236
| -0.3% | -$16.5K | 0.03% | 562 |
|
2025
Q1 | $5.43M | Buy |
73,882
+1,414
| +2% | +$104K | 0.03% | 482 |
|
2024
Q4 | $4.75M | Buy |
72,468
+17,721
| +32% | +$1.16M | 0.03% | 515 |
|
2024
Q3 | $4.27M | Buy |
54,747
+5,158
| +10% | +$402K | 0.03% | 535 |
|
2024
Q2 | $3.87M | Buy |
49,589
+5,779
| +13% | +$451K | 0.03% | 528 |
|
2024
Q1 | $2.97M | Buy |
43,810
+5,959
| +16% | +$404K | 0.03% | 550 |
|
2023
Q4 | $2.54M | Buy |
37,851
+3,425
| +10% | +$230K | 0.02% | 582 |
|
2023
Q3 | $2.33M | Buy |
34,426
+3,002
| +10% | +$203K | 0.03% | 554 |
|
2023
Q2 | $2.25M | Sell |
31,424
-1,170
| -4% | -$83.7K | 0.03% | 550 |
|
2023
Q1 | $2.26M | Sell |
32,594
-943
| -3% | -$65.5K | 0.03% | 497 |
|
2022
Q4 | $491K | Buy |
33,537
+1,857
| +6% | +$27.2K | 0.01% | 783 |
|
2022
Q3 | $1.74M | Buy |
31,680
+16
| +0.1% | +$878 | 0.03% | 466 |
|
2022
Q2 | $2.09M | Sell |
31,664
-16,442
| -34% | -$1.09M | 0.03% | 425 |
|
2022
Q1 | $3.19M | Buy |
48,106
+2,626
| +6% | +$174K | 0.05% | 319 |
|
2021
Q4 | $2.65M | Buy |
45,480
+1,130
| +3% | +$65.8K | 0.04% | 372 |
|
2021
Q3 | $2.66M | Sell |
44,350
-11,594
| -21% | -$696K | 0.07% | 266 |
|
2021
Q2 | $3.35M | Sell |
55,944
-3,033
| -5% | -$182K | 0.09% | 221 |
|
2021
Q1 | $2.93M | Sell |
58,977
-264,096
| -82% | -$13.1M | 0.09% | 220 |
|
2020
Q4 | $16.2M | Buy |
323,073
+308,954
| +2,188% | +$15.4M | 0.53% | 46 |
|
2020
Q3 | $774K | Buy |
+14,119
| New | +$774K | 0.03% | 451 |
|
2020
Q1 | – | Sell |
-4,913
| Closed | -$245K | – | 799 |
|
2019
Q4 | $245K | Sell |
4,913
-365
| -7% | -$18.2K | 0.01% | 719 |
|
2019
Q3 | $233K | Buy |
+5,278
| New | +$233K | 0.01% | 705 |
|
2017
Q3 | – | Sell |
-727
| Closed | -$24.4K | – | 421 |
|
2017
Q2 | $24.4K | Buy |
+727
| New | +$24.4K | ﹤0.01% | 677 |
|